Evergy Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Evergy Inc. Common Stock trades at $80.72 (market cap $18.57B), while Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B). The key difference: Evergy Inc. Common Stock is the larger of the two by market cap, and Evergy Inc. Common Stock pays a 3.45% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Evergy Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| EVRG | HALO | |
|---|---|---|
Market Cap | $18.57B | $12.58B |
Volume | 1,988,675 | 2,179,278 |
Sector | Utilities | Health |
52-Week High | $88.13 | $115.22 |
52-Week Low | $72.31 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $35.04B | $14.49B |
Dividend Yield | 3.45% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Evergy is a regulated electric utility serving customers in Kansas and Missouri. Its operations include electricity generation, transmission, and distribution through its integrated utility subsidiaries.
Read more on EVRG →Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →